The global Rabies Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Rabies Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rabies Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Rabies Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Rabies Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Cadila Healthcare
GlaxoSmithKline
Merial
Sanofi
Merck
Pfizer
Bayer
AstraZeneca
Amneal Pharmaceuticals
Anergis

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Cell culture vaccines (CCVs)
Rabies immunoglobulin (RIGs)
Nerve tissue vaccines (NTVs)

Segment by Application
Pre-exposure prophylaxis
Post-exposure prophylaxis